Turning Point Brands, Inc. (NYSE: TPB) announced a change in its executive leadership on September 21, 2026. The company’s Board of Directors has appointed David E. Glazek, the current Executive Chairman, as Chief Executive Officer, effective October 1, 2026. Mr. Glazek succeeds Graham Purdy, who has resigned as President and CEO for personal reasons. Mr. Purdy’s resignation is not related to any disagreement with the company and will be effective September 30, 2026.
Mr. Glazek has served as Executive Chairman of Turning Point Brands since 2023 and has been a director since 2012. He is 48 years old and currently serves as the Chairman of National CineMedia, Inc. (NASDAQ: NCMI) and an Adjunct Professor at Columbia Business School. Prior to joining Turning Point Brands, Mr. Glazek worked at Lazard Frères & Co., Standard General LP, and the Blackstone Group. He holds a BA in Economics and Political Science from the University of Michigan and a JD from Columbia Law School.
In a statement, Mr. Glazek expressed gratitude for Mr. Purdy’s more than two decades of service and highlighted the company’s strong balance sheet and iconic brand portfolio. He noted the transformative opportunity in the rapidly growing white pouch category. Mr. Purdy also commented on the rewarding nature of his tenure and thanked his colleagues and partners.
Separately, the company provided updated financial guidance for full-year 2026. Turning Point Brands reaffirmed its Modern Oral gross sales guidance range of $330 million to $350 million and net sales guidance of $260 million to $270 million. The company tightened its EBITDA guidance range to $70 million to $80 million, down from the previous range of $70 million to $90 million. This adjustment assumes no margin benefit from onshoring manufacturing until 2027 and prolonged, higher freight costs.
